Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Current Leases (2022 - 2025)

Rapid Micro Biosystems' Current Leases history spans 4 years, with the latest figure at $1.3 million for Q4 2025.

  • On a quarterly basis, Current Leases rose 6.92% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 6.92% increase, with the full-year FY2025 number at $1.3 million, up 6.92% from a year prior.
  • Current Leases hit $1.3 million in Q4 2025 for Rapid Micro Biosystems, up from $1.3 million in the prior quarter.
  • Over the last five years, Current Leases for RPID hit a ceiling of $1.3 million in Q4 2025 and a floor of $635000.0 in Q1 2022.
  • Historically, Current Leases has averaged $1.0 million across 4 years, with a median of $1.1 million in 2023.
  • Biggest five-year swings in Current Leases: surged 49.16% in 2024 and later rose 6.92% in 2025.
  • Tracing RPID's Current Leases over 4 years: stood at $766000.0 in 2022, then skyrocketed by 47.78% to $1.1 million in 2023, then grew by 7.24% to $1.2 million in 2024, then grew by 6.92% to $1.3 million in 2025.
  • Business Quant data shows Current Leases for RPID at $1.3 million in Q4 2025, $1.3 million in Q3 2025, and $1.3 million in Q2 2025.